2026 ICD-10-CM Diagnosis Code C94.6Myelodysplastic disease, not elsewhere classified
ICD-10-CM Codes›C00–D49›C81-C96›C94
- Billable — Valid for Submission
- Chronic Condition
C94.6 is a billable ICD-10-CM diagnosis code for myelodysplastic disease, not elsewhere classified. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 820 through 825, 840 through 842. Coders also document this condition as myelodysplastic/myeloproliferative disease. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Leukemia - all other types.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Myelodysplastic/myeloproliferative disease
- Myelodysplastic/myeloproliferative neoplasm, unclassifiable
- Pulmonary hypertension due to hematological disorder
- Pulmonary hypertension due to myeloproliferative disorder
- Vasculitis due to myeloproliferative disorder
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Myelodysplastic/myeloproliferative neoplasm, unclassifiable
- Myeloproliferative disease, not elsewhere classified
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Disease, diseased - See Also: Syndrome;
- myelodysplastic - See Also: Syndrome, myelodysplastic; - C94.6
- myelodysplastic/myeloproliferative neoplasm, unclassifiable - C94.6
- not classified - C94.6
- specified NEC - C94.6
- unclassifiable - C94.6
- Neoplasm, neoplastic - See Also: Table of Neoplasms;
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Disease, diseased
- myelodysplastic
- Disease, diseased
- myelodysplastic/myeloproliferative neoplasm, unclassifiable
- Disease, diseased
- myeloproliferative
- not classified
- Disease, diseased
- myeloproliferative
- specified NEC
- Disease, diseased
- myeloproliferative
- unclassifiable
- Neoplasm, neoplastic
- myelodysplastic/myeloproliferative, unclassifiable
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Myelodysplastic Syndromes
Your bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert C94.6 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About C94.6Overview
Is C94.6 (Other leukemias of specified cell type) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report myelodysplastic disease, not elsewhere classified on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does C94.6 group to?
When myelodysplastic disease, not elsewhere classified is the principal diagnosis on an inpatient stay, it groups to MS-DRG 820, 821, 822, 823, 824, 825, 840, 841, 842, with relative weights from 1.0104 to 5.8648 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of C94.6?
Under the General Equivalence Mappings, myelodysplastic disease, not elsewhere classified converts to ICD-9-CM 238.79 (lymph/hematpoitc tis NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
